Support WBURAt $2.1 Million, New Gene Therapy Is The Most Expensive Drug EverPlay04:19Download AudioRob SteinMay 24, 2019 ShareZolgensma, a new drug approved by the FDA Friday, costs more than $2.1 million. It's made by AveXis, a drugmaker owned by pharmaceutical giant Novartis. (Bloomberg via Getty Images)
